Magnesium Sulphate IV (Additional Indications)
Brand names: Magnesium Sulphate Injection
Intravenous magnesium sulphate used for additional emergency indications beyond eclampsia, including severe acute asthma as adjunctive therapy and certain unstable ventricular arrhythmias such as torsades de pointes.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Given intravenously, magnesium acts as a calcium antagonist and membrane stabiliser, relaxing bronchial and vascular smooth muscle and suppressing triggered cardiac activity that drives torsades.
Prescribing in practice
- Magnesium toxicity (loss of reflexes, respiratory depression, hypotension) is the principal danger, so monitor clinically and keep intravenous calcium available as the antidote.
- Lower the dose and monitor more intensively in renal impairment, where magnesium accumulates rapidly.
- Control the infusion rate, as rapid intravenous administration can precipitate flushing, hypotension and bradycardia.
Monitoring
Monitor reflexes, respiratory rate, blood pressure, cardiac rhythm and urine output during infusion, with serum magnesium levels in renal impairment or repeated dosing.
Counselling the patient
- Flushing or a feeling of warmth during the drip is common and usually settles quickly.
- Alert staff immediately if you feel weak, very drowsy or short of breath.
Evidence & guidelines
Intravenous magnesium as adjunct in severe asthma and for torsades de pointes is supported by national asthma guidance and resuscitation council recommendations.
Reference: BTS/SIGN Asthma Guideline 2023; Resuscitation Council TdP Algorithm; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Difficult Airway Algorithm (DAS) · DAS 2015; Royal College of Anaesthetists
- Major Haemorrhage Protocol · NICE NG24; UK MHP guidelines
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Featured in these MRCEM clinical pathways
Magnesium Sulphate IV (Additional Indications) is a core drug in the following exam-focused workups on our sister siteReviseMRCEM.
MRCEM Primary / Intermediate / OSCE candidates: each pathway includes exam-style questions, RCEM/NICE citations, and FAQ summaries.